...
首页> 外文期刊>Scientific reports. >Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
【24h】

Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia

机译:益生菌可能通过恢复肠道微生物群结构并改善肠内毒蛇血症来延迟非酒精性脂肪肝疾病的进展

获取原文

摘要

Gut-derived bacterial lipopolysaccharide (LPS) and subsequent hepatic toll-like receptor 4 (TLR4) activation have been recognized to be involved in the onset of diet-induced nonalcoholic fatty liver disease (NAFLD), but little is known about the variation of LPS and TLR4 during the progression of NAFLD. Probiotics were able to inhibit proliferation of harmful bacteria and improve gastrointestinal barrier function. However, it’s unclear whether LPS/TLR4 is involved in the protection effect of probiotics on NAFLD. In this study, we described characteristic of gut microbiota structure in the progression of NAFLD, and we also analyzed the relationship between gut microbiota and LPS/TLR4 in this process. Furthermore, we applied probiotics intervention to investigate the effect of probiotics on gut flora structure, intestinal integrity, serum LPS, liver TLR4 and liver pathology. Our results showed that serum LPS and liver TLR4 were highly increased during progression of NAFLD, with gut flora diversity and gut mircobiological colonization resistance (B/E) declining. Furthermore, probiotics could improve gut microbiota structure and liver pathology. Probiotics could also downregulate serum LPS and liver TLR4. Our results suggested that both gut flora alteration and endotoxemia may be involved in the progression of NAFLD. Probiotics may delay the progression of NAFLD via LPS/TLR4 signaling.
机译:已经认识到肠道衍生的细菌脂多糖(LPS)和随后的肝脏肝脏样受体4(TLR4)活化涉及饮食诱导的非酒精性脂肪肝疾病(NAFLD)的发作,但是关于LPS的变异很少和TLR4在NAFLD进展过程中。益生菌能够抑制有害细菌的增殖,改善胃肠屏障功能。然而,目前还不清楚LPS / TLR4是否参与益生菌对NAFLD的保护作用。在这项研究中,我们描述了NAFLD进展中肠道微生物群结构的特征,我们还在该过程中分析了Gut Microbiota和LPS / TLR4之间的关系。此外,我们应用益生菌干预以研究益生菌对肠道结构,肠完整,血清LPS,肝脏TLR4和肝病理学的影响。我们的研究结果表明,血清LPS和肝脏TLR4在NAFLD的进展过程中高度升高,肠道菌群多样性和肠道型致病性抗性(B / E)下降。此外,益生菌可以改善肠道微生物群结构和肝脏病理学。益生菌也可以下调血清LPS和肝脏TLR4。我们的结果表明,肠菌群变化和内毒素血症都可能参与NAFLD的进展。益生菌可能通过LPS / TLR4信号传导延迟NAFLD的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号